Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer (2023)
- Authors:
- USP affiliated authors: LOPES, LUCIANA BIAGINI - ICB ; PASSOS, JULIA SAPIENZA - ICB ; SALATA, GIOVANNA CASSONE - ICB ; MALAGÓ, ISABELLA DRASZESSKI - ICB ; DARTORA, VANESSA FRANCO CARVALHO - ICB
- Unidade: ICB
- DOI: 10.1016/j.ijpharm.2023.122681
- Subjects: FARMACOLOGIA; INIBIDORES DE ENZIMAS; NEOPLASIAS MAMÁRIAS; NANOTECNOLOGIA; ANTINEOPLÁSICOS; FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Pharmaceutics
- ISSN: 1873-3476
- Volume/Número/Paginação/Ano: v. 635, art. 122681, p. 1-15, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PASSOS, Julia Sapienza et al. Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer. International Journal of Pharmaceutics, v. 635, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.122681. Acesso em: 05 out. 2024. -
APA
Passos, J. S., Dartora, V. F. M. C., Salata, G. C., Malagó, I. D., & Lopes, L. B. (2023). Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer. International Journal of Pharmaceutics, 635, 1-15. doi:10.1016/j.ijpharm.2023.122681 -
NLM
Passos JS, Dartora VFMC, Salata GC, Malagó ID, Lopes LB. Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer [Internet]. International Journal of Pharmaceutics. 2023 ; 635 1-15.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.122681 -
Vancouver
Passos JS, Dartora VFMC, Salata GC, Malagó ID, Lopes LB. Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer [Internet]. International Journal of Pharmaceutics. 2023 ; 635 1-15.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.122681 - A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue
- Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment
- Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration
- Microemulsion for prolonged release of fenretinide in the mammary tissue and prevention of breast cancer development
- Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide
- Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment
- Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity
- Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment
- Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole
- Evaluation of polyelectrolyte nanoparticles of chitosan and hyaluronic acid as topical delivery systems for cytotoxic agents
Informações sobre o DOI: 10.1016/j.ijpharm.2023.122681 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
